Marketed as a fertility booster, the antioxidant Impryl showed no benefit in a large Dutch trial, and even reduced pregnancy rates at the critical treatment window, challenging supplement claims.
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback